The Latest Cardiac and Vascular News
Developed in partnership with Penumbra, Inc., Rapid Workflow for PE supports faster team activation to accelerate PE care and drive better patient outcomes SAN MATEO, Calif., June 24, 2021 /PRNewswire/ — RapidAI, leading the next evolution of clinical decision making and patient workflow, today announced the availability of Rapid Workflow for PE, a mobile […]
Now available in the U.S., RED™ 62 is engineered with optimized trackability to help navigate the complex distal vessel anatomy in the brain and deliver powerful aspiration for the removal of blood clots First catheter of new RED series expands the company’s extensive portfolio of innovative stroke products ALAMEDA, Calif.–(BUSINESS WIRE)–Penumbra, […]
Latest System Designed for Single Session Arterial Thrombus Removal ALAMEDA, Calif.–(BUSINESS WIRE)–Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. commercial availability of the Indigo® System Lightning™ 7. Lightning 7 expands Penumbra’s offering of the Indigo Aspiration System with Intelligent Aspiration for mechanical thrombectomy and is […]
– Partnership to be in tandem with formation of Genesis Medtech’s Neurovascular Franchise, pending an ongoing full acquisition of Hua Medtech – The collaboration will position Genesis MedTech (“Genesis”) as the largest local company in China’s neurovascular space SINGAPORE, Jan. 19, 2021 /PRNewswire/ — Genesis MedTech Group has reached a consensus to […]
A study published online first in the JACC: Cardiovascular Interventions found that Penumbra, Inc.’s Indigo Aspiration System met its predefined safety and efficacy endpoints for the treatment of pulmonary embolism (PE) in the EXTRACT-PE study. Specific results include a significant mean reduction in right ventricular (RV)/left ventricular (LV) ratio of […]
ALAMEDA, Calif., Jan. 11, 2021 /PRNewswire/ — Penumbra, Inc. (the “Company”) (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced certain unaudited preliminary revenue results for the fourth quarter and full year 2020 ahead of its participation at the 39th Annual J.P. Morgan Healthcare Conference on January 11-14, 2021. Q4 Revenue Highlights […]
Lightning 12 and Separator 12 Now Indicated for Treatment of PE ALAMEDA, Calif.–(BUSINESS WIRE)–Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. Food and Drug Administration 510(k) clearance for expanded indication of the latest iteration of the Indigo® Aspiration System, Lightning™ 12. As part of […]
ALAMEDA, Calif., Nov. 10, 2020 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced a new partnership to develop solutions to enable faster clinical decision-making for pulmonary embolism (PE) diagnosis and procedures with RapidAI, a company that offers a clinically proven, data-driven artificial intelligence (AI) platform […]
Launches Indigo® System Lightning™ 12 in U.S. Appoints Corey L. Teigen, M.D., as Chief Scientific Officer and James F. Benenati, M.D., FSIR, as Chief Medical Officer ALAMEDA, Calif.–(BUSINESS WIRE)–Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced its next phase for vascular franchise growth with U.S. […]
ALAMEDA, Calif.–(BUSINESS WIRE)–Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. Food and Drug Administration 510(k) clearance for expanded indication of the Indigo® Aspiration System. As part of the Indigo Aspiration System, the Indigo Aspiration Catheters and Separators are indicated for the removal of fresh, […]
